tiprankstipranks
Trending News
More News >
PharmX Technologies Limited (AU:PHX)
ASX:PHX
Australian Market

PharmX Technologies (PHX) Financial Statements

Compare
2 Followers

PharmX Technologies Financial Overview

PharmX Technologies's market cap is currently AU$86.93M. The company's EPS TTM is AU$-0.001; its P/E ratio is -375.00; PharmX Technologies is scheduled to report earnings on August 19, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19
Income Statement
Total Revenue
Gross Profit$ 10.52M$ 10.77M$ 7.91M$ 8.99M
Operating Income$ 340.00K$ -914.00K$ -1.33M$ -535.00K
EBITDA$ 2.54M$ 3.32M$ 1.31M$ -125.00K
Net Income$ 252.00K$ 1.09M$ 176.00K$ -4.21M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―
Total Assets$ 30.77M$ 31.35M$ 19.18M$ 15.04M
Total Debt$ 326.00K$ 321.00K$ 733.00K$ 0.00
Net Debt$ -5.43M$ -6.16M$ -1.59M$ -2.33M
Total Liabilities$ 7.57M$ 8.42M$ 5.98M$ 5.02M
Stockholders' Equity$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -694.00K$ -927.00K$ -2.92M$ -2.06M
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Currency in USD

PharmX Technologies Earnings and Revenue History

PharmX Technologies Debt to Assets

PharmX Technologies Cash Flow

PharmX Technologies Forecast EPS vs Actual EPS